d ‐Alanine Supplementation for Chronic Kidney Disease: A Study Protocol for a Pilot Randomized Controlled Trial
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202500746 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Megumi Oshima und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan. Hauptthemen laut MEDLINE: Alanine, Dietary Supplements, Renal Insufficiency, Chronic. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Patients with chronic kidney disease (CKD) are at high risk for kidney failure and cardiovascular events. d ‐alanine administration prevented kidney damage in a murine acute kidney injury model. This pilot trial aims to assist the design of a larger trial on the efficacy and safety of d ‐alanine intake on kidney function in patients with CKD. This pilot, open‐label, randomized controlled trial will enroll 24 patients with sustained albuminuria or proteinuria. Participants will be randomized in a 1:1 ratio to receive 3 g of d ‐alanine supplementation per day for 12 weeks or standard care alone. The primary endpoint will be change in albuminuria from baseline to 12 weeks. The secondary endpoints include changes in estimated glomerular filtration rate and other clinical parameters. Safety will be evaluated according to adverse events and laboratory parameters. The findings of this trial are expected to help design a larger‐scale trial of d ‐alanine and support further development of d ‐alanine as a novel nutrition management for CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
- Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
- Department of Clinical Laboratory, Kanazawa University, Kanazawa, Japan.
- Department of Rehabilitation, Kanazawa University Hospital, Kanazawa, Japan.
- Department of Nutrition, Kanazawa University Hospital, Kanazawa, Japan.
- KAGAMI INC., Ibaraki, Osaka, Japan.
ORCID-Profile: Megumi Oshima, Yasunori Iwata
Zitieren
APA
Oshima, M., Toyama, T., Nakade, Y., Sakurai, G., Yuasa, T., Koshino, A., Horikoshi, K., Minami, T., Sako, K., Nakagawa, S., Ito, K., Kitajima, S., Mizushima, I., Hara, A., Sakai, N., Shimizu, M., Tokumaru, T., Mita, M., Iwata, Y., & Wada, T. (2025). d ‐Alanine Supplementation for Chronic Kidney Disease: A Study Protocol for a Pilot Randomized Controlled Trial. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500746
Vancouver
Oshima M, Toyama T, Nakade Y, Sakurai G, Yuasa T, Koshino A, et al. d ‐Alanine Supplementation for Chronic Kidney Disease: A Study Protocol for a Pilot Randomized Controlled Trial. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500746
BibTeX
@article{Oshima2025,
author = {Oshima, Megumi and Toyama, Tadashi and Nakade, Yusuke and Sakurai, Goro and Yuasa, Takahiro and Koshino, Akihiko and Horikoshi, Keisuke and Minami, Taichiro and Sako, Keisuke and Nakagawa, Shiori and Ito, Kiyoaki and Kitajima, Shinji and Mizushima, Ichiro and Hara, Akinori and Sakai, Norihiko and Shimizu, Miho and Tokumaru, Toshiaki and Mita, Masashi and Iwata, Yasunori and Wada, Takashi},
title = {d ‐Alanine Supplementation for Chronic Kidney Disease: A Study Protocol for a Pilot Randomized Controlled Trial},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202500746}
}
EUVIMED